Clinical Trials
3 trialsNCT01044433 2020-03-19
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT00101075 2017-02-27
Title XELOX FOR SALIVARY GLAND CANCERS
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00448552 2016-12-15
Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer
University of Miami
Phase 2 Completed